What is the recommended dosing regimen of Polytrim (polymyxin B 0.1 mg/mL + trimethoprim 1 mg/mL) for a 17‑year‑old female?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 18, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Polytrim Dosing for a 17-Year-Old Female

For a 17-year-old female with bacterial conjunctivitis, instill one drop of Polytrim (polymyxin B/trimethoprim ophthalmic solution) in the affected eye(s) every 3 hours while awake (maximum 6 doses per day) for 7-10 days 1.

Dosing Algorithm

Standard Regimen

  • Frequency: 1 drop every 3 hours (maximum 6 doses/day)
  • Duration: 7-10 days
  • Application: Affected eye(s) only
  • Age consideration: Same dosing as adults since patient is >2 months old 1

Treatment Duration Decision Points

  • Mild to moderate infections: 7 days minimum
  • Severe infections or slow response: Extend to 10 days
  • Clinical improvement by day 4-6: Complete the full 7-day course regardless 2

Key Clinical Considerations

Efficacy Profile

While Polytrim remains effective for bacterial conjunctivitis, newer fluoroquinolones like moxifloxacin demonstrate faster symptom resolution (81% complete resolution at 48 hours vs 44% with Polytrim) 3. However, by day 7-10, clinical cure rates are equivalent (96% for Polytrim vs 95% for moxifloxacin), making Polytrim a cost-effective first-line option 2.

Important Caveats

  • Do not use contact lenses during treatment if signs/symptoms of bacterial infection present 1, 4
  • Avoid contaminating the dropper tip with fingers or ocular surface to maintain sterility 1
  • Discontinue immediately if hypersensitivity reactions (increased redness, swelling, pain) develop 4
  • Prolonged use (>10 days) may cause fungal superinfection; if symptoms persist beyond 10 days, re-evaluate 5

Special Population Considerations for 17-Year-Old Female

  • Pregnancy potential: If pregnant or planning pregnancy, use only if benefit outweighs risk due to trimethoprim's potential interference with folic acid metabolism 5, 4
  • No dose adjustment needed based on age alone since patient is well above the 2-month minimum age threshold 1

Expected Clinical Response Timeline

  • Day 1-2: Initial symptom improvement expected
  • Day 4-6: 72% of patients report clinical cure 2
  • Day 7-10: 96% clinical cure rate with complete symptom resolution 2

References

Related Questions

For a 17-year-old female with bacterial conjunctivitis, can Polytrim (polymyxin B 0.1 mg/mL + trimethoprim 1 mg/mL) be dosed every 6 hours?
What is the appropriate dosing schedule for a 1 mg/mL polymyxin B/trimethoprim ophthalmic solution?
Can Polytrim (polymyxin B 0.1%/trimethoprim 1%) be administered every 4 hours?
What is the appropriate dose of polymyxin B ophthalmic preparation for treating conjunctivitis in a 1‑year‑old child?
What is the dosing regimen for polymyxin B/trimethoprim (Poly‑Mix) and plain trimethoprim eye drops for conjunctivitis?
What is the appropriate antibiotic treatment for bacterial conjunctivitis (pink eye) in a 17‑year‑old female without known drug allergies?
In an asthmatic patient who meets rapid sequence intubation criteria, is ketamine preferred over etomidate?
What are the recommended preventive and treatment measures for fungal infections in disaster settings, including exposure avoidance, protective equipment, early diagnosis, and appropriate antifungal therapy?
How soon before surgery should GLP‑1 receptor agonist injections be stopped?
For a 17-year-old female with bacterial conjunctivitis, can Polytrim (polymyxin B 0.1 mg/mL + trimethoprim 1 mg/mL) be dosed every 6 hours?
What is gain‑of‑function research and what biosafety and regulatory measures are required for it?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.